Quinn机会伙伴公司出售了Kenvue股份,但本季度股票仍然上涨了300.8%。 Quinn Opportunity Partners sold Kenvue shares, but the stock still rose 300.8% this quarter.

昆茵机会伙伴有限责任公司在第四季度出售了65 000个Kenvue股份,减少了股份,而斯科舍资本公司增加了6 252个股份。 Quinn Opportunity Partners LLC sold 65,000 Kenvue Inc. shares in the fourth quarter, reducing their holdings, while Scotia Capital Inc. increased its stake by 6,252 shares. 肯武尔的股票尽管减少,却上涨了300%。 Despite the reduction, Kenvue's stock rose 300.8%. 消费者保健公司的市场上限为422.5亿美元,其中部分为 " 自我护理 " 、 " 皮肤健康和美容 " 以及 " 基本保健 " 。 The consumer health company has a market cap of $42.25 billion, with segments in Self Care, Skin Health and Beauty, and Essential Health. 分析员预测,当年每股收入为1.14美元,股票评级为“稳住”,目标价格为24.42美元。 Analysts predict earnings per share of $1.14 for the year, and the stock has a "Hold" rating with a target price of $24.42.